The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Brentuximab vedotin + AVD for newly diagnosed classic Hodgkin lymphoma (cHL): Incidence and management of peripheral neuropathy in a multi-institution cohort.
 
Jackson Bowers
No Relationships to Disclose
 
Jacob Anna
No Relationships to Disclose
 
Steven Michael Bair
Consulting or Advisory Role - Abbvie; Arcellx (I); TG Therapeutics
 
Kaitlin Annunzio
No Relationships to Disclose
 
Narendranath Epperla
Honoraria - Genzyme
Consulting or Advisory Role - Beigene; Karyopharm Therapeutics; Novartis; TG therapeutics
Speakers' Bureau - Incyte
Research Funding - AstraZeneca; Secura Bio
 
Jerrin Joy Pullukkara
No Relationships to Disclose
 
Sameh Gaballa
Consulting or Advisory Role - ADC Therapeutics; BeiGene; Epizyme; Kite, a Gilead Company
Speakers' Bureau - ADC Therapeutics; Lilly O.
 
Michael Spinner
Consulting or Advisory Role - Kite, a Gilead company
 
Shuning Li
No Relationships to Disclose
 
Marcus Messmer
Stock and Other Ownership Interests - Schrodinger
 
Joseph Nguyen
No Relationships to Disclose
 
Emily C. Ayers
No Relationships to Disclose
 
Charlotte Burton Wagner
Employment - Abbvie (I)
Consulting or Advisory Role - Pfizer
 
Boyu Hu
Honoraria - Guidepoint Inc
Consulting or Advisory Role - ADC Therapeutics; BeiGene; Bristol-Myers Squibb/Celgene; Genmab; Lilly; Novartis; TG Therapeutics
Speakers' Bureau - Binacea; OncLive/MJH Life Sciences; Patient Power; Total Health Conferencing
Research Funding - Caribou Biosciences (Inst); Celgene (Inst); crispr therapeutics (Inst); MorphoSys/Incyte (Inst); Repare Therapeutics (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - DAVA Oncology
 
Mengyang Di
No Relationships to Disclose
 
Scott F. Huntington
Honoraria - AstraZeneca; Pharmacyclics; Seagen
Consulting or Advisory Role - Abbvie; ADC Therapeutics; Arvinas; AstraZeneca; Bayer; BeiGene; Epizyme; Flatiron Health; Genentech; Janssen; Merck; Novartis; SeaGen; TG Therapeutics; Tyme Inc.
Research Funding - Agios; Celgene; Debiopharm Group; DTRM; TG Therapeutics
Travel, Accommodations, Expenses - Bayer; Celgene; Genentech; Pharmacyclics
 
Fateeha Furqan
No Relationships to Disclose
 
Nirav Niranjan Shah
Stock and Other Ownership Interests - Tundra Targeted Therapeutics
Consulting or Advisory Role - Incyte; Janssen Oncology; Juno/Bristol-Myers Sqibb; Kite, a Gilead company; Loxo/Lilly; Novartis; Seagen; TG Therapeutics
Research Funding - Adaptive Biotechnologies; Loxo/Lilly; Miltenyi Biotec
Travel, Accommodations, Expenses - Miltenyi Biotec
 
Christina Chen
No Relationships to Disclose
 
Jakub Svoboda
Consulting or Advisory Role - Adaptive Biotechnologies; AstraZeneca; Atara Biotherapeutics; BMS; Pharmacyclics; Seagen
Research Funding - Adaptive Biotechnologies (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Merck (Inst); Pharmacyclics (Inst); Seagen (Inst); TG Therapeutics (Inst)